A rank-based mixed model approach to multisite clinical trials.

Area of Science:

• Biostatistics
• Clinical Trial Design
• Statistical Modeling

Background:

• Current rank methods have limitations in analyzing multisite clinical trial data.
• Existing approaches may not adequately account for random drug-by-site interactions.

Purpose of the Study:

• To introduce novel rank-based statistical methods for analyzing data from multisite clinical trials.
• To develop procedures that can detect drug main effects in the presence of random drug-by-site interactions.

Main Methods:

• Development of new rank-based procedures within the framework of mixed linear models.
• Application of analogous procedures for fixed-effects models.
• Comparison of new methods with existing rank-based techniques.

Main Results:

• The proposed methods effectively test for drug main effects, even with random drug-by-site interactions.
• New procedures are also applicable to fixed-effects scenarios, offering flexibility.
• Demonstration of the rationale for analyses incorporating random investigator effects.

Conclusions:

• The new rank-based methods provide a robust approach for analyzing multisite clinical trial data.
• These methods improve the ability to detect treatment effects in complex trial designs.
• The study offers valuable statistical tools for biostatisticians and clinical researchers.